During the past decade, İzmir Medical Park; Onkoloji conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "İzmir Medical Park; Onkoloji" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator and "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "İzmir Medical Park; Onkoloji" are "Adenocarcinoma" (1 trials), "Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers" (1 trials), "Bronchial Diseases" (1 trials), "Cancer of Unknown Primary Site" (1 trials) and "Carcinoma" (1 trials). Many other conditions were trialed in "İzmir Medical Park; Onkoloji" in a lesser frequency.

Most popular intervention types in "İzmir Medical Park; Onkoloji" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Atezolizumab" (3 trials), "Gemcitabine" (3 trials), "Cisplatin" (2 trials) and "Etoposide" (2 trials). Other intervention names were less common.

The vast majority of trials in "İzmir Medical Park; Onkoloji" are 5 trials for "All" genders.

Currently, there are NaN active trials in "İzmir Medical Park; Onkoloji". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in İzmir Medical Park; Onkoloji, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in İzmir Medical Park; Onkoloji, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".